Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2016 (2016), Article ID 4513089, 9 pages
http://dx.doi.org/10.1155/2016/4513089
Review Article

Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?

1Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA
2Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
3Division of Women’s Health, Brigham and Women’s Hospital, 1620 Tremont Street, OBC-34, Boston, MA 02120, USA

Received 2 January 2016; Revised 4 April 2016; Accepted 5 April 2016

Academic Editor: Louise Hafner

Copyright © 2016 Samsiya Ona et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. E. Manhart, “Mycoplasma genitalium: an emergent sexually transmitted disease?” Infectious Disease Clinics of North America, vol. 27, no. 4, pp. 779–792, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Gaydos, N. E. Maldeis, A. Hardick, J. Hardick, and T. C. Quinn, “Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics,” Sexually Transmitted Diseases, vol. 36, no. 10, pp. 598–606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. E. Manhart, K. K. Holmes, J. P. Hughes, L. S. Houston, and P. A. Totten, “Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection,” American Journal of Public Health, vol. 97, no. 6, pp. 1118–1125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Taylor-Robinson and J. S. Jensen, “Mycoplasma genitalium: from chrysalis to multicolored butterfly,” Clinical Microbiology Reviews, vol. 24, no. 3, pp. 498–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. L. E. Manhart, J. S. Jensen, C. S. Bradshaw, M. R. Golden, and D. H. Martin, “Efficacy of antimicrobial therapy for Mycoplasma genitalium infections,” Clinical Infectious Diseases, vol. 61, supplement 8, pp. S802–S817, 2015. View at Publisher · View at Google Scholar
  6. J. E. Korte, J. B. Baseman, M. P. Cagle et al., “Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium,” American Journal of Reproductive Immunology, vol. 55, no. 4, pp. 265–275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Schlicht, S. D. Lovrich, J. S. Sartin, P. Karpinsky, S. M. Callister, and W. A. Agger, “High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin,” Journal of Clinical Microbiology, vol. 42, no. 10, pp. 4636–4640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Oakeshott, A. Aghaizu, P. Hay et al., “Is Mycoplasma genitalium in women the ‘new chlamydia?’ A community-based prospective cohort study,” Clinical Infectious Diseases, vol. 51, no. 10, pp. 1160–1166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Lis, A. Rowhani-Rahbar, and L. E. Manhart, “Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis,” Clinical Infectious Diseases, vol. 61, no. 3, pp. 418–426, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Lillis, M. J. Nsuami, L. Myers, and D. H. Martin, “Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women,” Journal of Clinical Microbiology, vol. 49, no. 5, pp. 1990–1992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. V. L. Mobley, M. M. Hobbs, K. Lau, B. S. Weinbaum, D. K. Getman, and A. C. Seña, “Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors,” Sexually Transmitted Diseases, vol. 39, no. 9, pp. 706–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. A. Workowski and G. A. Bolan, “Sexually transmitted diseases treatment guidelines, 2015,” MMWR Recommendations and Reports, vol. 64, no. 3, pp. 1–137, 2015. View at Google Scholar
  13. C. L. Haggerty and B. D. Taylor, “Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease,” Infectious Diseases in Obstetrics and Gynecology, vol. 2011, Article ID 959816, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. STDs in Women and Infants—2014 STD Surveillance. (n.d.), March 2016, http://www.cdc.gov/std/stats14/womenandinf.htm#pid.
  15. C. L. Haggerty, P. A. Totten, S. G. Astete et al., “Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 84, no. 5, pp. 338–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Horner, K. Blee, and E. Adams, “Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!,” Current Opinion in Infectious Diseases, vol. 27, no. 1, pp. 68–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Tagg, N. J. Jeoffreys, D. L. Couldwell, J. A. Donald, and G. L. Gilbert, “Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium,” Journal of Clinical Microbiology, vol. 51, no. 7, pp. 2245–2249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Chrisment, A. Charron, C. Cazanave, S. Pereyre, and C. Bébéar, “Detection of macrolide resistance in Mycoplasma genitalium in France,” The Journal of Antimicrobial Chemotherapy, vol. 67, no. 11, pp. 2598–2601, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. K. Tosh, B. Van Der Pol, J. D. Fortenberry et al., “Mycoplasma genitalium among adolescent women and their partners,” Journal of Adolescent Health, vol. 40, no. 5, pp. 412–417, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Thurman, O. Musatovova, S. Perdue, R. N. Shain, J. G. Baseman, and J. B. Baseman, “Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads,” International Journal of STD & AIDS, vol. 21, no. 3, pp. 177–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. D. C. Ross, L. Brown, P. Saunders, and S. Alexander, “Mycoplasma genitalium in asymptomatic patients: implications for screening,” Sexually Transmitted Infections, vol. 85, no. 6, pp. 436–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Andersen, I. Sokolowski, L. Østergaard, J. K. Møller, F. Olesen, and J. S. Jensen, “Mycoplasma qenitalium: prevalence and behavioural risk factors in the general population,” Sexually Transmitted Infections, vol. 83, no. 3, pp. 237–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Falk, H. Fredlund, and J. S. Jensen, “Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection,” Sexually Transmitted Infections, vol. 81, no. 1, pp. 73–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Smieszek and P. J. White, “Apparently-different clearance rates from cohort studies of mycoplasma genitalium are consistent after accounting for incidence of infection, recurrent infection, and study design,” PLoS ONE, vol. 11, no. 2, Article ID 0149087, 2016. View at Publisher · View at Google Scholar
  25. B. Clarivet, E. Picot, H. Marchandin et al., “Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic,” European Journal of Dermatology, vol. 24, no. 5, pp. 611–616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. E. B. Hancock, L. E. Manhart, S. J. Nelson, R. Kerani, J. K. H. Wroblewski, and P. A. Totten, “Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women,” Sexually Transmitted Diseases, vol. 37, no. 12, pp. 777–783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Bjartling, S. Osser, and K. Persson, “Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service,” American Journal of Obstetrics and Gynecology, vol. 206, no. 6, pp. 476.e1–476.e8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Uno, T. Deguchi, H. Komeda et al., “Mycoplasma genitalium in the cervices of Japanese women,” Sexually Transmitted Diseases, vol. 24, no. 5, pp. 284–286, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Gomih-Alakija, J. Ting, N. Mugo et al., “Clinical characteristics associated with Mycoplasma genitalium among female sex workers in nairobi, Kenya,” Journal of Clinical Microbiology, vol. 52, no. 10, pp. 3660–3666, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. S. Bradshaw, M. Y. Chen, and C. K. Fairley, “Persistence of Mycoplasma genitalium following azithromycin therapy,” PLoS ONE, vol. 3, no. 11, Article ID e3618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Andersen, I. Sokolowski, L. Østergaard, J. Kjølseth Møller, F. Olesen, and J. S. Jensen, “Mycoplasma genitalium: prevalence and behavioural risk factors in the general population,” Sexually Transmitted Infections, vol. 83, no. 3, pp. 237–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. F. Clausen, J. Fedder, M. Drasbek et al., “Serological investigation of Mycoplasma genitalium in infertile women,” Human Reproduction, vol. 16, no. 9, pp. 1866–1874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. H. F. Svenstrup, J. Fedder, S. E. Kristoffersen, B. Trolle, S. Birkelund, and G. Christiansen, “Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility-a prospective study,” Fertility and Sterility, vol. 90, no. 3, pp. 513–520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Grześko, M. Elias, B. Maczyńska, U. Kasprzykowska, M. Tłaczała, and M. Goluda, “Occurrence of Mycoplasma genitalium in fertile and infertile women,” Fertility and Sterility, vol. 91, no. 6, pp. 2376–2380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Peuchant, C. Le Roy, C. Desveaux et al., “Screening for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium should it be integrated into routine pregnancy care in French young pregnant women?” Diagnostic Microbiology and Infectious Disease, vol. 82, no. 1, pp. 14–19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Sonnenberg, C. A. Ison, S. Clifton et al., “Epidemiology of Mycoplasma genitalium in British men and women aged 16-44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3),” International Journal of Epidemiology, vol. 44, no. 6, pp. 1982–1994, 2015. View at Publisher · View at Google Scholar
  37. C. Cazanave, L. E. Manhart, and C. Bébéar, “Mycoplasma genitalium, an emerging sexually transmitted pathogen,” Médecine et Maladies Infectieuses, vol. 42, no. 9, pp. 381–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Walker, C. K. Fairley, C. S. Bradshaw et al., “Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women,” Clinical Infectious Diseases, vol. 56, no. 8, pp. 1094–1100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. H. F. Svenstrup, S. S. Dave, C. Carder et al., “A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London,” BMJ Open, vol. 4, no. 2, Article ID e003947, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Quentin and R. Verdon, “Microbiologic basis of diagnosis and treatment of pelvic inflammatory disease,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 41, no. 8, pp. 850–863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. R. B. Ness, D. E. Soper, J. Peipert et al., “Design of the PID Evaluation and Clinical Health (PEACH) study,” Controlled Clinical Trials, vol. 19, no. 5, pp. 499–514, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Das, G. De la Garza, E. B. Siwak, V. L. Scofield, and S. Dhandayuthapani, “Mycoplasma genitalium promotes epithelial crossing and peripheral blood mononuclear cell infection by HIV-1,” International Journal of Infectious Diseases, vol. 23, pp. e31–e38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Vandepitte, H. A. Weiss, J. Bukenya et al., “Association between Mycoplasma genitalium infection and HIV acquisition among female sex workers in Uganda: evidence from a nested case-control study,” Sexually Transmitted Infections, vol. 90, no. 7, pp. 545–549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Zarei, S. Rezania, and A. Mousavi, “Mycoplasma genitalium and cancer: a brief review,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 6, pp. 3425–3428, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Taylor-Robinson and R. F. Lamont, “Mycoplasmas in pregnancy,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 118, no. 2, pp. 164–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. K. B. Waites, R. L. Schelonka, L. Xiao, P. L. Grigsby, and M. J. Novy, “Congenital and opportunistic infections: ureaplasma species and Mycoplasma hominis,” Seminars in Fetal and Neonatal Medicine, vol. 14, no. 4, pp. 190–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. G. Tully, D. Taylor-Robinson, R. M. Cole, and D. L. Rose, “A newly discovered mycoplasma in the human urogenital tract,” The Lancet, vol. 317, no. 8233, pp. 1288–1291, 1981. View at Publisher · View at Google Scholar · View at Scopus
  48. H. F. Svenstrup, J. S. Jensen, E. Björnelius, P. Lidbrink, S. Birkelund, and G. Christiansen, “Development of quantitative real-time PCR assay for detection of Mycoplasma genitalium,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3121–3128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. A. Weinstein and B. G. Stiles, “A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium,” Sexual Health, vol. 8, no. 2, pp. 143–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Edwards, P. Burke, H. B. Smalley et al., “Loop-mediated isothermal amplification (LAMP) for the rapid detection of Mycoplasma genitalium,” Diagnostic Microbiology and Infectious Disease, vol. 83, no. 1, pp. 13–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. J. K. H. Wroblewski, L. E. Manhart, K. A. Dickey, M. K. Hudspeth, and P. A. Totten, “Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium,” Journal of Clinical Microbiology, vol. 44, no. 9, pp. 3306–3312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. L. A. Mena, T. F. Mroczkowski, M. Nsuami, and D. H. Martin, “A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men,” Clinical Infectious Diseases, vol. 48, no. 12, pp. 1649–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. C. S. Bradshaw, J. S. Jensen, S. N. Tabrizi et al., “Azithromycin failure in Mycoplasma genitalium urethritis,” Emerging Infectious Diseases, vol. 12, no. 7, pp. 1149–1152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Lau, C. S. Bradshaw, D. Lewis et al., “The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 61, no. 9, pp. 1389–1399, 2015. View at Publisher · View at Google Scholar
  55. M. Bissessor, S. N. Tabrizi, J. Twin et al., “Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens,” Clinical Infectious Diseases, vol. 60, no. 8, pp. 1228–1236, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Jernberg, A. Moghaddam, and H. Moi, “Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study,” International Journal of STD & AIDS, vol. 19, no. 10, pp. 676–679, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. D. C. Ross, H. S. Cronjé, T. Paszkowski et al., “Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial,” Sexually Transmitted Infections, vol. 82, no. 6, pp. 446–451, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. D. L. Couldwell, K. A. Tagg, N. J. Jeoffreys, and G. L. Gilbert, “Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance,” International Journal of STD and AIDS, vol. 24, no. 10, pp. 822–828, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Deguchi, M. Kikuchi, M. Yasuda, and S. Ito, “Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV,” Journal of Infection and Chemotherapy, vol. 21, no. 1, pp. 74–75, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. D. L. Couldwell and D. A. Lewis, “Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations,” Infection and Drug Resistance, vol. 8, pp. 147–161, 2016. View at Publisher · View at Google Scholar
  61. Z. Gundevia, R. Foster, M. S. Jamil, and A. McNulty, “Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort,” Sexually Transmitted Infections, vol. 91, no. 1, pp. 11–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Falk, M. Enger, and J. S. Jensen, “Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women,” The Journal of Antimicrobial Chemotherapy, vol. 70, no. 11, pp. 3134–3140, 2015. View at Publisher · View at Google Scholar
  63. S. Ito, K. Mizutani, K. Seike et al., “Prediction of the persistence of Mycoplasma genitalium after antimicrobial chemotherapy by quantification of leukocytes in firstvoid urine from patients with non-gonococcal urethritis,” Journal of Infection and Chemotherapy, vol. 20, no. 5, pp. 298–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Westrom, R. Joesoef, G. Reynolds, A. Hagdu, and S. E. Thompson, “Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results,” Sexually Transmitted Diseases, vol. 19, no. 4, pp. 185–192, 1992. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Vandepitte, H. A. Weiss, N. Kyakuwa et al., “Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda,” Sexually Transmitted Diseases, vol. 40, no. 5, pp. 422–427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Jurstrand, J. S. Jensen, A. Magnuson, F. Kamwendo, and H. Fredlund, “A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy,” Sexually Transmitted Infections, vol. 83, no. 4, pp. 319–323, 2007. View at Publisher · View at Google Scholar · View at Scopus